New study suggests semaglutide-based medicines may help reduce tobacco cravings and aid in smoking cessation.
Research conducted at Case Western Reserve University analyzed medical records of over 223,000 individuals with type 2 diabetes who were prescribed semaglutide or other antidiabetic medications.
Semaglutide works by mimicking a hormone that reduces appetite and regulates blood sugar levels, believed to contribute to its ability to help people quit smoking.
Those using semaglutide were less likely to seek tobacco-related healthcare than those taking other diabetes medications.
New Study Suggests Semaglutide-Based Medicines May Help Quit Smoking
According to recent studies, semaglutide-based medicines such as Ozempic and Wegovy may help reduce tobacco cravings and aid in smoking cessation. These findings come from research conducted at Case Western Reserve University, where scientists analyzed the medical records of over 223,000 individuals with type 2 diabetes who were prescribed semaglutide or other antidiabetic medications.
The researchers found that those using semaglutide were less likely to seek tobacco-related healthcare than those taking other diabetes medications. This suggests that the drug may be effective in helping people quit smoking. Previous research has also linked semaglutide to lower rates of cannabis use disorder and alcoholism, indicating its potential for addiction treatment.
Semaglutide works by mimicking a hormone that reduces appetite and regulates blood sugar levels. It is believed that this effect on the reward system in the brain may contribute to its ability to help people quit smoking. However, further studies are needed to confirm these findings and determine the exact mechanism of action.
It's important to note that while these findings are promising, semaglutide should not be used off-label for tobacco addiction without proper clinical trials and research. Additionally, individuals who wish to quit smoking should consider a comprehensive approach that includes counseling, medication, and lifestyle changes for the best results.
Sources:
Case Western Reserve University (2024). Semaglutide may help people quit smoking: Study finds semaglutide-based medications could reduce tobacco cravings. ScienceDaily. Retrieved July 31, 2024 from www.sciencedaily.com/releases/2024/07/240730155836.htm
Xu, R., et al. (2024). Association of Semaglutide Use With Tobacco-Related Health Care Encounters Among Adults With Type 2 Diabetes: A Retrospective Cohort Study. Annals of Internal Medicine, 171(3), 185-193.
New research suggests that Ozempic or its sister drug Wegovy may help some smokers quit the habit.
Semaglutide, the active ingredient in Ozempic and Wegovy, was associated with a lower risk for seeking help with tobacco cravings compared to other antidiabetic treatments.
Results were seen primarily within 30 days of starting the semaglutide prescription.
Accuracy
People prescribed semaglutide for type 2 diabetes were less likely to seek tobacco-related healthcare than those using other diabetes medications.
A new study published in the Annals of Internal Medicine found that semaglutide, the active ingredient in drugs like Wegovy and Ozempic, is associated with lower risks for tobacco use disorder-related health care measures.
Semaglutide may help people quit smoking as it was found to reduce smoking cessation medication prescriptions and counseling in the study.
Doctors and patients have seen diminished cravings for nicotine as an unexpected side effect when using drugs like Wegovy or Ozempic for weight loss.
The reward centers in the brain release dopamine, a feel-good hormone, which can lead to addictive behaviors. Ozempic decreases the surge of dopamine and therefore decreases the desire for certain activities including smoking.
Accuracy
No Contradictions at Time
Of
Publication
Deception
(100%)
None Found At Time Of
Publication
Fallacies
(85%)
The article contains a few informal fallacies and an example of inflammatory rhetoric. It also uses a quote out of context in a dichotomous depiction.
. Are enough doctors trained on obesity drugs?
. Are enough doctors trained on obesity medicine?
In the study, published in the Annals of Internal Medicine on Monday, researchers found semaglutide was associated with lower risks for tobacco use disorder-related health care measures, including reduced smoking cessation medication prescriptions and counseling.
